TabacaleraYsidron Overview

  • Founded
  • 2011
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 2

TabacaleraYsidron General Information

Description

Mount TAM Biotechnologies Inc is a biopharmaceutical company operating in the US. Its core business is to optimize, develop a portfolio of products focused on improving the health and wellbeing of individuals afflicted with serious diseases, with a key product targeting systemic lupus erythematosus (SLE) and a strategy to bring to market novel therapeutics across a range of serious disease areas. The company mainly focuses on the development of a product candidate in the field of SLE, an autoimmune disorder where treatments are inadequate to control disease and a condition where serious unmet need remains. It product candidates is TAM-01 and TAM-03 which are novel rapalogs in action of binding and inhibition of the mammalian Target of Rapamycin.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Other Consumer Non-Durables
Primary Office
  • 100 Europa Drive
  • Suite 455
  • Chapel Hill, NC 27517
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

TabacaleraYsidron Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore TabacaleraYsidron‘s full profile, request access.

Request a free trial